Nutex Health (NUTX) Competitors $92.40 -3.78 (-3.93%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$93.13 +0.73 (+0.79%) As of 08/22/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUTX vs. PINC, FIVN, ACVA, ALIT, VVX, LZ, UPWK, RAMP, OLO, and PHRShould you be buying Nutex Health stock or one of its competitors? The main competitors of Nutex Health include Premier (PINC), Five9 (FIVN), ACV Auctions (ACVA), Alight (ALIT), V2X (VVX), LegalZoom.com (LZ), Upwork (UPWK), LiveRamp (RAMP), OLO (OLO), and Phreesia (PHR). These companies are all part of the "business services" industry. Nutex Health vs. Its Competitors Premier Five9 ACV Auctions Alight V2X LegalZoom.com Upwork LiveRamp OLO Phreesia Premier (NASDAQ:PINC) and Nutex Health (NASDAQ:NUTX) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability. Do analysts rate PINC or NUTX? Premier presently has a consensus target price of $24.00, indicating a potential downside of 4.53%. Nutex Health has a consensus target price of $262.50, indicating a potential upside of 184.09%. Given Nutex Health's stronger consensus rating and higher possible upside, analysts clearly believe Nutex Health is more favorable than Premier.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Premier 1 Sell rating(s) 8 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.89Nutex Health 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings & valuation, PINC or NUTX? Premier has higher revenue and earnings than Nutex Health. Nutex Health is trading at a lower price-to-earnings ratio than Premier, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPremier$1.01B2.04$119.54M$0.22114.27Nutex Health$792.21M0.65$52.18M$11.897.77 Is PINC or NUTX more profitable? Nutex Health has a net margin of 10.76% compared to Premier's net margin of 2.00%. Nutex Health's return on equity of 42.08% beat Premier's return on equity.Company Net Margins Return on Equity Return on Assets Premier2.00% 7.04% 3.75% Nutex Health 10.76%42.08%11.80% Which has more risk & volatility, PINC or NUTX? Premier has a beta of 0.56, meaning that its stock price is 44% less volatile than the S&P 500. Comparatively, Nutex Health has a beta of 0.05, meaning that its stock price is 95% less volatile than the S&P 500. Do insiders and institutionals believe in PINC or NUTX? 74.4% of Premier shares are owned by institutional investors. Comparatively, 5.3% of Nutex Health shares are owned by institutional investors. 1.0% of Premier shares are owned by insiders. Comparatively, 36.9% of Nutex Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media prefer PINC or NUTX? In the previous week, Premier had 28 more articles in the media than Nutex Health. MarketBeat recorded 44 mentions for Premier and 16 mentions for Nutex Health. Premier's average media sentiment score of 0.78 beat Nutex Health's score of -0.08 indicating that Premier is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Premier 11 Very Positive mention(s) 6 Positive mention(s) 19 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nutex Health 0 Very Positive mention(s) 2 Positive mention(s) 10 Neutral mention(s) 1 Negative mention(s) 3 Very Negative mention(s) Neutral SummaryPremier and Nutex Health tied by winning 8 of the 16 factors compared between the two stocks. Get Nutex Health News Delivered to You Automatically Sign up to receive the latest news and ratings for NUTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NUTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUTX vs. The Competition Export to ExcelMetricNutex HealthMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$513.29M$7.82B$5.81B$9.76BDividend YieldN/A2.69%4.39%4.06%P/E Ratio7.7778.4731.3626.05Price / Sales0.6550.60387.8788.42Price / Cash7.0225.3638.0259.36Price / Book2.4924.799.536.60Net Income$52.18M$243.33M$3.26B$265.65M7 Day Performance-0.55%1.08%2.14%2.00%1 Month Performance-3.50%0.70%3.22%0.46%1 Year Performance327.18%10.42%30.18%18.88% Nutex Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUTXNutex Health2.6164 of 5 stars$92.40-3.9%$262.50+184.1%+327.2%$513.29M$792.21M7.771,150Upcoming EarningsPINCPremier2.3381 of 5 stars$24.43-2.1%$22.20-9.1%+22.6%$2.05B$1.26B42.862,900Trending NewsDividend AnnouncementAnalyst ForecastFIVNFive94.3515 of 5 stars$26.40+1.4%$37.59+42.4%-18.4%$2.01B$1.04B293.373,073News CoveragePositive NewsOptions VolumeACVAACV AuctionsN/A$11.58-1.1%N/AN/A$2.00B$637.16M-29.692,900ALITAlight4.5284 of 5 stars$3.89+6.3%$8.94+129.8%-46.1%$1.97B$2.33B-1.769,500News CoverageVVXV2X3.6886 of 5 stars$61.85+0.5%$63.36+2.4%+3.2%$1.95B$4.32B28.1116,100Positive NewsLZLegalZoom.com1.6637 of 5 stars$10.86+1.3%$9.92-8.7%+66.0%$1.93B$681.88M67.881,220Positive NewsInsider TradeUPWKUpwork2.8594 of 5 stars$13.99+1.4%$18.67+33.4%+48.9%$1.83B$769.33M8.04850Insider TradeRAMPLiveRamp4.7672 of 5 stars$26.99+1.4%$40.83+51.3%+11.5%$1.75B$745.58M122.691,300Analyst DowngradeOLOOLO2.9086 of 5 stars$10.22+0.0%$10.17-0.5%+86.1%$1.73B$284.94M145.86710News CoveragePositive NewsShort Interest ↓PHRPhreesia3.9634 of 5 stars$29.06+1.3%$32.27+11.1%+17.3%$1.71B$419.81M-39.272,082News CoveragePositive News Related Companies and Tools Related Companies Premier Alternatives Five9 Alternatives ACV Auctions Alternatives Alight Alternatives V2X Alternatives LegalZoom.com Alternatives Upwork Alternatives LiveRamp Alternatives OLO Alternatives Phreesia Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NUTX) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutex Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nutex Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access